CLASS II ONGOING Drug recall · Reported 11 Nov 2026 · FDA Enforcement Report
Delflex Peritoneal Dialysis Solution with 1.5% Dextrose recalled
Fresenius Medical Care Renal Therapies Group is recalling Delflex Peritoneal Dialysis Solution with 1.5% Dextrose, Low Magnesium/ Low Calcium and, distributed nationwide in the US. The recall was initiated on 14 Oct 2026 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0169-2027
- FDA event ID
- 100130
- Recalling firm
- Fresenius Medical Care Renal Therapies Group, Lawrence, MA
- Brand
- Delflex
- Manufacturer
- Fresenius Medical Care de Mexico, S.A. de C.V.
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- 14 Oct 2026
- FDA classified
- 3 Nov 2026
- Reported
- 11 Nov 2026
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Sterility
- Drug class
- Injectable & IV Drugs
Timeline
| 14 Oct 2026 | Recall initiated by company | |
| 3 Nov 2026 | Classified by FDA | +20 days |
| 11 Nov 2026 | Published in enforcement report | +8 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Lack of Assurance of Sterility:complaints have been received related to potential leaks from small perforations in the print area on the primary bag in the affected lots.
A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.
Product as listed by the FDA
DELFLEX Peritoneal Dialysis Solution with 1.5% Dextrose, Low Magnesium/ Low Calcium and Attached stay safe Exchange Set, 2,500 mL Single dose bag, Sterile and Non-Pyrogenic, Rx only, CAT. NO. 054-25321. Fresenius Medical Care, Renal Therapies Group, LLC, Lawrence, MA 01843. NDC 46163-206-94
Where it was distributed
Nationwide in the USA.
Questions about this recall
Why was it recalled?
Lack of Assurance of Sterility:complaints have been received related to potential leaks from small perforations in the print area on the primary bag in the affected lots.
Which lots are affected?
Lot#: 25HGPD037, Exp 12/31/2026; 26CGPD074, Exp 9/30/2027.
Where was it sold?
Nationwide in the USA.
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 17 Nov 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
Other products in this recall event
4 other products · FDA event 100130This product is part of a recall event; the main page for the event is Delflex Peritoneal Dialysis Solution with 4.25% Dextrose recalled.
| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| CLASS II | Delflex Peritoneal Dialysis Solution with 4.25% Dextrose recalledDelflex | Fresenius Medical Care Renal Therapies Group | Sterility | Nationwide | |
| CLASS II | Delflex Peritoneal Dialysis Solution with 2.5% Dextrose recalledDelflex | Fresenius Medical Care Renal Therapies Group | Sterility | Nationwide | |
| CLASS II | Delflex Peritoneal Dialysis Solution with 1.5% Dextrose recalledDelflex | Fresenius Medical Care Renal Therapies Group | Sterility | Nationwide | |
| CLASS II | Delflex Peritoneal Dialysis Solution with 2.5% Dextrose recalledDelflex | Fresenius Medical Care Renal Therapies Group | Sterility | Nationwide |
More recalls from Fresenius Medical Care Renal Therapies Group
All 40| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Delflex Peritoneal Dialysis Solution with 2.5% Dextrose recalledDelflex | Fresenius Medical Care Renal Therapies Group | Sterility | Nationwide |
| Drug | CLASS II | Delflex Peritoneal Dialysis Solution with 1.5% Dextrose recalledDelflex | Fresenius Medical Care Renal Therapies Group | Sterility | Nationwide |
| Drug | CLASS II | Delflex Peritoneal Dialysis Solution with 2.5% Dextrose recalledDelflex | Fresenius Medical Care Renal Therapies Group | Sterility | Nationwide |
| Drug | CLASS II | Delflex Peritoneal Dialysis Solution with 4.25% Dextrose recalledDelflex | Fresenius Medical Care Renal Therapies Group | Sterility | Nationwide |
| Device | CLASS II | CombiSet Hemodialysis Blood Tubing Set recalled | Fresenius Medical Care Renal Therapies Group | Other | Nationwide |
Other Dextrose recalls
All 42| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Delflex Peritoneal Dialysis Solution with 2.5% Dextrose recalledDelflex | Fresenius Medical Care Renal Therapies Group | Sterility | Nationwide |
| Drug | CLASS II | Delflex Peritoneal Dialysis Solution with 1.5% Dextrose recalledDelflex | Fresenius Medical Care Renal Therapies Group | Sterility | Nationwide |
| Drug | CLASS II | Delflex Peritoneal Dialysis Solution with 2.5% Dextrose recalledDelflex | Fresenius Medical Care Renal Therapies Group | Sterility | Nationwide |
| Drug | CLASS II | Delflex Peritoneal Dialysis Solution with 4.25% Dextrose recalledDelflex | Fresenius Medical Care Renal Therapies Group | Sterility | Nationwide |
| Drug | CLASS I | Dextrose Injection, USP, 70 % recalled by Baxter Healthcare | Baxter Healthcare | Particulate Matter | Nationwide |